Search hospitals

>

Nebraska

>

Omaha

Children's Hospital and Medical Center of Omaha

Claim this profile

Omaha, Nebraska 68114

Global Leader in Cancer

Global Leader in Brain Tumor

Conducts research for Neuroblastoma

Conducts research for Soft Tissue Sarcoma

Conducts research for Rhabdomyosarcoma

197 reported clinical trials

7 medical researchers

Photo of Children's Hospital and Medical Center of Omaha in OmahaPhoto of Children's Hospital and Medical Center of Omaha in Omaha

Summary

Children's Hospital and Medical Center of Omaha is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Soft Tissue Sarcoma, Rhabdomyosarcoma and other specialties. Children's Hospital and Medical Center of Omaha is involved with conducting 197 clinical trials across 347 conditions. There are 7 research doctors associated with this hospital, such as Jill C. Beck, Minnie Abromowitch, Chittalsinh Raulji, MD, and Sookyong Koh, MD, PhD.

Area of expertise

1

Cancer

Global Leader

Children's Hospital and Medical Center of Omaha has run 45 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Brain Tumor

Global Leader

Children's Hospital and Medical Center of Omaha has run 39 trials for Brain Tumor. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital and Medical Center of Omaha

Brain Tumor

Testicular cancer

Wilms Tumor

Burkitt Lymphoma

Neuroblastoma

Cancer

Leukemia

Acute Lymphoblastic Leukemia

Biphenotypic Leukemia

Acute Leukemia

Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital and Medical Center of Omaha?